What is the recommended management for an otherwise healthy adult patient presenting with a urinary tract infection (UTI)?

Management of Urinary Tract Infection in Otherwise Healthy Adults

For uncomplicated cystitis in otherwise healthy adults, initiate nitrofurantoin 100 mg twice daily for 5 days as first-line therapy, which provides robust efficacy while sparing broader-spectrum agents for more serious infections. 1

Diagnosis and Initial Assessment

Clinical Diagnosis

• Acute-onset dysuria is the cornerstone symptom with >90% accuracy for UTI in young women when vaginal irritation or discharge is absent. 2
• Additional symptoms include urgency, frequency, hematuria, suprapubic pain, and new incontinence, though these may be variably present 2
• In women with typical symptoms and no vaginal discharge, diagnosis can be made clinically without office visit or urine culture 3, 4

When to Obtain Urine Culture

• Reserve urine culture for: recurrent infections, treatment failure, history of resistant organisms, atypical presentation, or in all men with UTI symptoms 2, 4
• Obtain culture before initiating antibiotics when testing is indicated 2

First-Line Antibiotic Treatment

Uncomplicated Cystitis in Women

Three equally appropriate first-line options exist: 1, 3, 4

1. Nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5 days 1

   • Preferred choice due to excellent efficacy and minimal collateral damage to normal flora 1
   • Spares systemically active agents for other infections 1

2. Fosfomycin trometamol 3 g single oral dose 1, 3

   • Convenient single-dose therapy 1

3. Trimethoprim-sulfamethoxazole (TMP-SMX) 160/800 mg (1 DS tablet) twice daily for 3 days 1, 5, 3

   • Only use if local resistance rates are <20% 3
   • Avoid in patients with recent antibiotic exposure or risk factors for ESBL-producing organisms 6

Alternative Second-Line Options

• Fluoroquinolones (ciprofloxacin 250 mg twice daily for 3 days OR levofloxacin 750 mg once daily for 3 days) 1

  • Reserve for more invasive infections due to collateral damage concerns 1, 3
  • Should not be first-line for uncomplicated cystitis 3

• β-lactams (amoxicillin-clavulanate, cephalexin, cefpodoxime) are less effective as empirical first-line therapy 3

Uncomplicated Cystitis in Men

• Always obtain urine culture before treatment 4
• First-line options: TMP-SMX, trimethoprim, or nitrofurantoin for 7 days 2, 4
• Consider urethritis and prostatitis in differential diagnosis 4
• Limited evidence supports 7-14 days of therapy 7

Pyelonephritis (Upper UTI)

Empirical Treatment Selection

For patients requiring oral therapy: 1

• TMP-SMX or first-generation cephalosporin (e.g., cephalexin) are reasonable first-line agents, dependent on local resistance rates <20% 1

For patients requiring intravenous therapy: 1, 8

• Ceftriaxone is the recommended empirical choice due to low resistance rates and clinical effectiveness 1
• Avoid antipseudomonal agents unless risk factors for nosocomial pathogens exist 1

Treatment Duration for Pyelonephritis

• β-lactams: 7 days 1
• Fluoroquinolones: 5-7 days 1
• Levofloxacin 750 mg once daily for 5 days may be considered for non-severely ill patients 7

Special Considerations

Women with Diabetes

• Treat similarly to women without diabetes when no voiding abnormalities are present 3
• Same first-line agents and durations apply 3

Older Adults (≥65 years)

• Obtain urine culture with susceptibility testing to guide therapy 4
• First-line antibiotics and treatment durations do not differ from younger adults 4
• Symptoms may be less clear; carefully evaluate chronicity 2

Catheter-Associated UTI

• Obtain urine culture from freshly placed catheter before initiating therapy 7
• Replace catheter if in place >2 weeks at onset of CA-UTI to hasten symptom resolution 7
• Treatment duration: 7 days for prompt symptom resolution, 10-14 days for delayed response 7

Antimicrobial Stewardship Principles

Key Strategies

• Avoid fluoroquinolones and cephalosporins as first-line for uncomplicated cystitis to preserve their effectiveness 2
• Select agents with least impact on normal vaginal and fecal flora 2
• Tailor empirical therapy based on local antibiogram data 1, 2
• Adjust therapy based on culture results when available 8

Risk Factors for Multidrug-Resistant Organisms

Consider broader coverage when: 1

• Recent antibiotic exposure
• Healthcare-associated infection
• Known colonization with resistant organisms
• Severe clinical presentation combined with local resistance patterns

Treatment Failure

Definition and Management

• No universal definition exists; generally includes clinical failure, microbiological failure, or both 1
• Risk factors: older age, diabetes, septic shock, pregnancy, immunosuppression 1
• Obtain repeat culture if treatment failure suspected 2
• Consider urologic evaluation for anatomic abnormalities 2

Common Pitfalls to Avoid

1. Do not treat asymptomatic bacteriuria in non-pregnant, non-catheterized patients 2
2. Do not use moxifloxacin for UTI due to uncertain urinary concentrations 7
3. Do not routinely obtain cystoscopy or upper tract imaging for uncomplicated recurrent UTI 2
4. Do not use broad-spectrum agents empirically without risk factors for resistance 1
5. Avoid treating positive urine cultures in catheterized patients without symptoms 1